Advanced Biomed (ADVB) Other Non-Current Liabilities (2025)
Advanced Biomed (ADVB) posted Other Non-Current Liabilities of $114065.0 for Q4 2025, down 40.27% sequentially from $190959.0 in Q3 2025.
Advanced Biomed (ADVB) Other Non-Current Liabilities (2025) Analysis & Trends
Advanced Biomed has reported Other Non-Current Liabilities for 1 years, with the latest figure at $114065.0 in Q4 2025.
- Quarterly Other Non-Current Liabilities changed N/A year-over-year to $114065.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $114065.0 (changed N/A YoY) and the FY2025 annual result came in at $69975.0, changed N/A from the prior year.
- Other Non-Current Liabilities eased to $114065.0 in Q4 2025 per ADVB's latest filing, from $190959.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $190959.0 in Q3 2025 and troughed at $69975.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Advanced Biomed | 12.28 Mn | 12.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 114,065.00 |
| Sep 30, 2025 | 190,959.00 |
| Jun 30, 2025 | 69,975.00 |